Real-time near-infrared fluorescence reporting the azoreductase-triggered drug release

2020 ◽  
Vol 11 (3) ◽  
pp. 734-743
Author(s):  
Yuqing Wang ◽  
Jiawei Yu ◽  
Zhe Wang ◽  
Shahid Iqbal ◽  
Wei Zhang ◽  
...  

Herein, real-time near-infrared fluorescence reporting drug release was demonstrated by the azoreductase-induced cleavage of azo bonds and the subsequent disassembly of aggregates, which caused an enhancement in fluorescence intensity.

2015 ◽  
Vol 51 (32) ◽  
pp. 6948-6951 ◽  
Author(s):  
Yanfeng Zhang ◽  
Qian Yin ◽  
Jonathan Yen ◽  
Joanne Li ◽  
Hanze Ying ◽  
...  

Anin vitroandin vivodrug-reporting system is developed for real-time monitoring of drug release via the analysis of the concurrently released near-infrared fluorescence dye.


2021 ◽  
Author(s):  
Qiuying Song ◽  
Bo Zhou ◽  
Dongyu Zhang ◽  
Haijun Chi ◽  
Hongmin Jia ◽  
...  

The development of well-designed fluorescence probes for the monitoring redox homeostasis in biosystems has become a desired research field owing to their noninvasive and real-time detection capability in vivo. In...


2017 ◽  
Vol 29 (40) ◽  
pp. 1703702 ◽  
Author(s):  
Chunlei Zhu ◽  
Da Huo ◽  
Qiaoshan Chen ◽  
Jiajia Xue ◽  
Song Shen ◽  
...  

2021 ◽  
Author(s):  
Biswajit Roy ◽  
Rakesh Mengji ◽  
Samrat Roy ◽  
Bipul Pal ◽  
Avijit Jana ◽  
...  

In recent times, organelle-targeted drug delivery systems gained tremendous attention due to the site specific delivery of active drug molecules resulting in enhanced bioefficacy. In this context, the phototriggered drug delivery system (DDS) for releasing an active molecule is superior as it provides spatial and temporal control over the release. So far, near infrared (NIR) light responsive organelle targeted DDS has not yet been developed. Hence, we introduced a two-photon NIR-light responsive lysosome targeted ʽAIE + ESIPTʼ active single component DDS based on naphthalene chromophore. The Two-photon absorption cross-section of our DDS is 142 GM at 850 nm. The DDS was converted into pure organic nanoparticles for biological applications. Our nano-DDS is capable of selective targeting, AIE-luminogenic imaging, and drug release within the lysosome. In vitro studies using cancerous cell lines showed that our single component photoresponsive nanocarrier exhibited enhanced cytotoxicity and real-time monitoring ability of the drug release.


2018 ◽  
Vol 6 (21) ◽  
pp. 3531-3540 ◽  
Author(s):  
Jun Xiang ◽  
Xia Tong ◽  
Feng Shi ◽  
Qiang Yan ◽  
Bing Yu ◽  
...  

The preparation of a new near-infrared (NIR) light-responsive nanocarrier for controlled drug release is demonstrated.


Sign in / Sign up

Export Citation Format

Share Document